Pinku Mukherjee - Publications

Biology (PhD) University of North Carolina, Charlotte, Charlotte, NC, United States 
Cell Biology, Oncology, Molecular Biology

103 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Sahraei M, Bose M, Sanders JA, De C, DasRoy L, Nath S, Brouwer CR, Mukherjee P. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models. International Journal of Molecular Sciences. 22. PMID 34070449 DOI: 10.3390/ijms22115587  1
2021 Bose M, Mitra B, Mukherjee P. Reply to the letter from Dr. Pirjo Pärnänen et al. Physiological Reports. 9: e14743. PMID 33527777 DOI: 10.14814/phy2.14743  0.44
2021 Bose M, Mitra B, Mukherjee P. Mucin signature as a potential tool to predict susceptibility to COVID-19. Physiological Reports. 9: e14701. PMID 33373502 DOI: 10.14814/phy2.14701  0.44
2020 Zhou R, Yazdanifar M, Roy LD, Whilding LM, Gavrill A, Maher J, Mukherjee P. Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth. Frontiers in Immunology. 11: 628776. PMID 33365036 DOI: 10.3389/fimmu.2020.628776  0.52
2020 Bose M, Mukherjee P. Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers. Vaccines. 8. PMID 33167508 DOI: 10.3390/vaccines8040659  0.44
2020 Kelly VJ, Wu ST, Gottumukkala V, Coelho R, Palmer K, Nair S, Erick T, Puri R, Ilovich O, Mukherjee P. Preclinical evaluation of an In/Ac theranostic targeting transformed MUC1 for triple negative breast cancer. Theranostics. 10: 6946-6958. PMID 32550914 DOI: 10.7150/Thno.38236  0.12
2019 Lin Y, Raj J, Li J, Ha A, Hossain MA, Richardson C, Mukherjee P, Yan S. APE1 senses DNA single-strand breaks for repair and signaling. Nucleic Acids Research. PMID 31828326 DOI: 10.1093/Nar/Gkz1175  0.01
2019 Bose M, Mukherjee P. Microbe-MUC1 Crosstalk in Cancer-Associated Infections. Trends in Molecular Medicine. PMID 31753595 DOI: 10.1016/J.Molmed.2019.10.003  0.44
2019 Curry JM, Besmer DM, Erick TK, Steuerwald N, Das Roy L, Grover P, Rao S, Nath S, Ferrier JW, Reid RW, Mukherjee P. Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice. Plos One. 14: e0224309. PMID 31693710 DOI: 10.1371/Journal.Pone.0224309  1
2019 Erick TK, Mukherjee P. Modulating MUC1 Function on T Cells. Trends in Immunology. PMID 31653412 DOI: 10.1016/J.It.2019.09.007  0.01
2019 Bose M, Mukherjee P. Role of Microbiome in Modulating Immune Responses in Cancer. Mediators of Inflammation. 2019: 4107917. PMID 31308831 DOI: 10.1155/2019/4107917  0.44
2019 Zhou R, Yazdanifar M, Roy LD, Whilding LM, Gavrill A, Maher J, Mukherjee P. CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth. Frontiers in Immunology. 10: 1149. PMID 31178870 DOI: 10.3389/Fimmu.2019.01149  0.52
2019 Dréau D, Moore LJ, Wu M, Roy LD, Dillion L, Porter T, Puri R, Momin N, Wittrup KD, Mukherjee P. Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 9: 330. PMID 31114758 DOI: 10.3389/Fonc.2019.00330  0.52
2019 Zhao H, Richardson R, Talebloo N, Mukherjee P, Wang P, Moore A. uMUC1-Targeting Magnetic Resonance Imaging of Therapeutic Response in an Orthotropic Mouse Model of Colon Cancer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 30793239 DOI: 10.1007/s11307-019-01326-5  0.01
2019 Yazdanifar M, Zhou R, Wu S, Grover P, Mukherjee P. Abstract 584: Developing a novel engineered T cell to target resistant pancreatic cancer Immunology. DOI: 10.1158/1538-7445.Sabcs18-584  0.52
2019 Zhou R, Yazdanifar M, Roy LD, Maher J, Mukherjee P. Abstract 2305: Tumor MUC1 glycoprotein-highly specific CAR T cells control triple-negative breast cancer Immunology. DOI: 10.1158/1538-7445.Sabcs18-2305  0.52
2019 ilovich o, Kelly V, Wu S, Gottumukkala V, Coelho R, Puri R, Mukherjee P. Abstract LB-281: Development and non-clinical evaluation of an111In/225Ac theranostic for triple negative breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-281  0.36
2019 Grover P, Zhou R, Yazdanifar M, Ahmad M, Puri A, Grover K, Shi X, Mukherjee P. Abstract 2636: Tumor associated MUC1 mediates TGF-β in pancreatic cancer Cancer Research. 79: 2636-2636. DOI: 10.1158/1538-7445.Am2019-2636  0.52
2019 Bose M, Mukherjee P. Abstract 2052: A novel antibody blocks anti-apoptotic activity of MUC1 in pancreatic cancer cell lines Cancer Research. 79: 2052-2052. DOI: 10.1158/1538-7445.Am2019-2052  0.44
2018 Wu ST, Fowler AJ, Garmon CB, Fessler AB, Ogle JD, Grover KR, Allen BC, Williams CD, Zhou R, Yazdanifar M, Ogle CA, Mukherjee P. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles. Bmc Cancer. 18: 457. PMID 29685122 DOI: 10.1186/S12885-018-4393-7  0.36
2018 Nazari SS, Mukherjee P. An overview of mammographic density and its association with breast cancer. Breast Cancer (Tokyo, Japan). PMID 29651637 DOI: 10.1007/S12282-018-0857-5  0.01
2018 Grover P, Nath S, Nye MD, Zhou R, Ahmad M, Mukherjee P. SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line. Oncotarget. 9: 6897-6910. PMID 29467938 DOI: 10.18632/Oncotarget.23966  1
2018 Wu ST, Williams CD, Grover PA, Moore LJ, Mukherjee P. Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004. Plos One. 13: e0193260. PMID 29462213 DOI: 10.1371/Journal.Pone.0193260  0.12
2017 Roy LD, Dillon LM, Zhou R, Moore LJ, Livasy C, El-Khoury JM, Puri R, Mukherjee P. A tumor specific antibody to aid breast cancer screening in women with dense breast tissue. Genes & Cancer. 8: 536-549. PMID 28680538 DOI: 10.18632/Genesandcancer.134  0.52
2017 Mukherjee P, Zhou R, Yazdanifar M, Lopamudra DR. Abstract A37: Development and future of CAR T cell therapy for pancreatic ductal adenocarcinoma and triple negative breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Newfront17-A37  0.36
2017 Yazdanifar M, Zhou R, Wu S, Grover P, Mukherjee P. Abstract 4708: A novel anti-MUC1 CAR T cell drives immunity to pancreatic cancer Cancer Research. 77: 4708-4708. DOI: 10.1158/1538-7445.Am2017-4708  0.52
2017 Grover P, Nye MD, Yazdanifar M, Ahmad M, Zhou R, Roy LD, Grover K, Wu S, Nath S, Mukherjee P. Abstract 321: MUC1 regulates TGFβ function in pancreatic cancer Cancer Research. 77: 321-321. DOI: 10.1158/1538-7445.Am2017-321  1
2016 Yazdanifar M, Zhou R, Mukherjee P. Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells. Current Trends in Immunology. 17: 95-115. PMID 28659689  0.36
2016 Dréau D, Moore LJ, Alvarez-Berrios MP, Tarannum M, Mukherjee P, Vivero-Escoto JL. Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective Breast Cancer Detection in a Mucin-1 Transgenic Murine Mouse Model. Journal of Biomedical Nanotechnology. 12: 2172-2184. PMID 28522938 DOI: 10.1166/Jbn.2016.2318  0.12
2016 Moore LJ, Roy LD, Zhou R, Grover P, Wu ST, Curry JM, Dillon LM, Puri PM, Yazdanifar M, Puri R, Mukherjee P, Dréau D. Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors. Translational Oncology. 9: 295-305. PMID 27567952 DOI: 10.1016/j.tranon.2016.05.001  1
2016 Pathangey LB, Lakshminarayanan V, Suman VJ, Pockaj BA, Mukherjee P, Gendler SJ. Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes. Biomolecules. 6. PMID 27367740 DOI: 10.3390/biom6030031  0.48
2016 Wang P, Yoo B, Sherman S, Mukherjee P, Ross A, Pantazopoulos P, Petkova V, Farrar C, Medarova Z, Moore A. Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer. International Journal of Cancer. PMID 26996122 DOI: 10.1002/ijc.30098  0.01
2016 Zhou R, Curry JM, Roy LD, Grover P, Haider J, Moore LJ, Wu ST, Kamesh A, Yazdanifar M, Ahrens WA, Leung T, Mukherjee P. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis. Oncogene. PMID 26804176 DOI: 10.1038/Onc.2015.516  1
2016 Roy LD, Zhou R, Dillon L, Moore L, Puri R, Marks J, Lyerly H, Mukherjee P. Abstract P4-09-16: A monoclonal antibody with exceptional specificity across major breast cancer subtypes Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P4-09-16  0.52
2016 Wu S, Fowler AJ, Ogle C, Mukherjee P. Abstract 1323: Targeting tMUC1 for the diagnostics and treatment of pancreatic cancer Cancer Research. 76: 1323-1323. DOI: 10.1158/1538-7445.Am2016-1323  0.36
2015 Moore LJ, Das Roy L, Wu ST, Puri R, Mukherjee P. Early detection of mammary tumors in vivo using a highly specific tumor antibody. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 14. PMID 28147824 DOI: 10.1200/Jco.2015.33.28_Suppl.14  0.12
2015 Nath S, Roy LD, Grover P, Rao S, Mukherjee P. Mucin 1 Regulates Cox-2 gene in Pancreatic Cancer. Pancreas. PMID 26035123 DOI: 10.1097/Mpa.0000000000000371  1
2015 Grover P, Nath S, Ahmad M, Mukherjee P. Abstract 2054: In pancreatic cancer, MUC1 regulates function of TGF-β and thus enhances metastasis Cancer Research. 75: 2054-2054. DOI: 10.1158/1538-7445.Am2015-2054  1
2014 Nath S, Bhowmick S, Dutta T, Chowrasia VR, Bhattacharya S, Chatterjee RN, Sarkar M, Ram AK, Mukherjee PK. A study of promotional advertisements of drugs in a medical journal: an ethics perspective. Indian Journal of Medical Ethics. 11: 237-41. PMID 25377037  1
2014 Roy LD, Sahraei M, Schettini JL, Gruber HE, Besmer DM, Mukherjee P. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches. Bmc Cancer. 14: 225. PMID 24674692 DOI: 10.1186/1471-2407-14-225  1
2014 Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends in Molecular Medicine. 20: 332-42. PMID 24667139 DOI: 10.1016/J.Molmed.2014.02.007  1
2014 Panni RZ, Sanford DE, Belt BA, Mitchem JB, Worley LA, Goetz BD, Mukherjee P, Wang-Gillam A, Link DC, Denardo DG, Goedegebuure SP, Linehan DC. Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. Cancer Immunology, Immunotherapy : Cii. 63: 513-28. PMID 24652403 DOI: 10.1007/S00262-014-1527-X  1
2014 Kidiyoor A, Schettini J, Besmer DM, Rego SL, Nath S, Curry JM, Roy LD, Dréau D, Mukherjee P. Pancreatic Cancer Cells Isolated from Muc1-Null Tumors Favor the Generation of a Mature Less Suppressive MDSC Population. Frontiers in Immunology. 5: 67. PMID 24605110 DOI: 10.3389/Fimmu.2014.00067  1
2014 Wu S, Fowler A, Ogle C, Mukherjee P. Abstract 4484: Anti-cancer treatments delivered by antibody guided PLGA nanoparticles Cancer Research. 74: 4484-4484. DOI: 10.1158/1538-7445.Am2014-4484  0.36
2014 Zhou R, Curry J, Grover P, Roy LD, Leung T, Mukherjee P. Abstract 26: MUC1 enhances neuropilin-1 signaling in pancreatic ductal adenocarcinoma Cancer Research. 74: 26-26. DOI: 10.1158/1538-7445.Am2014-26  0.52
2013 Hastie E, Besmer DM, Shah NR, Murphy AM, Moerdyk-Schauwecker M, Molestina C, Roy LD, Curry JM, Mukherjee P, Grdzelishvili VZ. Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma. Journal of Virology. 87: 10283-94. PMID 23864625 DOI: 10.1128/Jvi.01412-13  1
2013 Rego SL, Swamydas M, Kidiyoor A, Helms R, De Piante A, Lance AL, Mukherjee P, Dréau D. Soluble tumor necrosis factor receptors shed by breast tumor cells inhibit macrophage chemotaxis. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 33: 672-81. PMID 23777205 DOI: 10.1089/Jir.2013.0009  1
2013 Nath S, Daneshvar K, Roy LD, Grover P, Kidiyoor A, Mosley L, Sahraei M, Mukherjee P. MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes. Oncogenesis. 2: e51. PMID 23774063 DOI: 10.1038/oncsis.2013.16  1
2013 Das Roy L, Curry JM, Sahraei M, Besmer DM, Kidiyoor A, Gruber HE, Mukherjee P. Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling. Breast Cancer Research : Bcr. 15: R32. PMID 23577751 DOI: 10.1186/Bcr3412  1
2013 Curry JM, Thompson KJ, Rao SG, Besmer DM, Murphy AM, Grdzelishvili VZ, Ahrens WA, McKillop IH, Sindram D, Iannitti DA, Martinie JB, Mukherjee P. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer. Journal of Surgical Oncology. 107: 713-22. PMID 23335066 DOI: 10.1002/Jso.23316  1
2013 Moerdyk-Schauwecker M, Shah NR, Murphy AM, Hastie E, Mukherjee P, Grdzelishvili VZ. Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. Virology. 436: 221-34. PMID 23246628 DOI: 10.1016/J.Virol.2012.11.014  1
2013 Curry JM, Besmer DM, Roy LD, Grover P, Nath S, Rao S, Mukherjee P. Abstract 475: Combinational treatment with MUC1 vaccine and Indomethacin reduces breast tumor burden via a COX-independent pathway. Cancer Research. 73: 475-475. DOI: 10.1158/1538-7445.Am2013-475  1
2013 Nath S, Roy LD, Rao S, Grover P, Mukherjee P. Abstract 3119: MUC1 transcriptionally regulates COX-2 gene in pancreatic cancer cells. Cancer Research. 73: 3119-3119. DOI: 10.1158/1538-7445.Am2013-3119  1
2013 Rego S, Helms R, Piante AD, Kidiyoor A, Lance A, Mukherjee P, Dréau D. Abstract 1540: TNFRs shed by tumor cells inhibit the migration of macrophages. Cancer Research. 73: 1540-1540. DOI: 10.1158/1538-7445.Am2013-1540  0.52
2012 Chauhan VS, Nelson DA, Roy LD, Mukherjee P, Bost KL. Exacerbated metastatic disease in a mouse mammary tumor model following latent gammaherpesvirus infection. Infectious Agents and Cancer. 7: 11. PMID 22642913 DOI: 10.1186/1750-9378-7-11  1
2012 Schettini J, Kidiyoor A, Besmer DM, Tinder TL, Roy LD, Lustgarten J, Gendler SJ, Mukherjee P. Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity. Cancer Immunology, Immunotherapy : Cii. 61: 2055-65. PMID 22543528 DOI: 10.1007/S00262-012-1264-Y  0.52
2012 Sahraei M, Roy LD, Curry JM, Teresa TL, Nath S, Besmer D, Kidiyoor A, Dalia R, Gendler SJ, Mukherjee P. MUC1 regulates PDGFA expression during pancreatic cancer progression. Oncogene. 31: 4935-45. PMID 22266848 DOI: 10.1038/Onc.2011.651  1
2012 Murphy AM, Besmer DM, Moerdyk-Schauwecker M, Moestl N, Ornelles DA, Mukherjee P, Grdzelishvili VZ. Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma. Journal of Virology. 86: 3073-87. PMID 22238308 DOI: 10.1128/Jvi.05640-11  1
2012 Nath S, Daneshvar K, Puri N, Mukherjee P. Abstract LB-348: Chemoresistance in pancreatic cancer is conferred by MUC1 cytoplasmic tail binding to the promoter region of the ABCC1 (MRP-1) gene Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-348  1
2012 Besmer D, Kidiyoor A, Nath S, Roy LD, Curry J, Mukherjee P. Abstract 5400: Investigating the role of IDO in MUC1 expressing breast cancers Cancer Research. 72: 5400-5400. DOI: 10.1158/1538-7445.Am2012-5400  1
2012 Murphy A, Besmer D, Moerdyk-Schauwecker M, Moestl N, Ornelles D, Mukherjee P, Grdzelishvili V. Abstract 2714: Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma Cancer Research. 72: 2714-2714. DOI: 10.1158/1538-7445.Am2012-2714  0.48
2012 Roy LD, Curry JM, Sahraei M, Kidiyoor A, Besmer DM, Gruber HE, Mukherjee P. Abstract 1389: Arthritis augments breast cancer metastasis: Role of mast cells and SCF/c-Kit signaling Cancer Research. 72: 1389-1389. DOI: 10.1158/1538-7445.Am2012-1389  0.6
2011 Roy LD, Ghosh S, Pathangey LB, Tinder TL, Gruber HE, Mukherjee P. Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer. Bmc Cancer. 11: 365. PMID 21859454 DOI: 10.1186/1471-2407-11-365  1
2011 Pinkhasov J, Alvarez ML, Rigano MM, Piensook K, Larios D, Pabst M, Grass J, Mukherjee P, Gendler SJ, Walmsley AM, Mason HS. Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice. Plant Biotechnology Journal. 9: 991-1001. PMID 21740504 DOI: 10.1111/J.1467-7652.2011.00614.X  1
2011 Besmer DM, Curry JM, Roy LD, Tinder TL, Sahraei M, Schettini J, Hwang SI, Lee YY, Gendler SJ, Mukherjee P. Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis. Cancer Research. 71: 4432-42. PMID 21558393 DOI: 10.1158/0008-5472.Can-10-4439  0.6
2011 Roy LD, Sahraei M, Subramani DB, Besmer D, Nath S, Tinder TL, Bajaj E, Shanmugam K, Lee YY, Hwang SI, Gendler SJ, Mukherjee P. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene. 30: 1449-59. PMID 21102519 DOI: 10.1038/Onc.2010.526  1
2011 Kidiyoor A, Schettini J, Roy LD, Besmer D, Tinder T, Mukherjee P. Abstract 3644: Pancreatic tumor cells that develop within Muc1 knock-out mice generate less immunosuppressive MDSCs in vitro Cancer Research. 71: 3644-3644. DOI: 10.1158/1538-7445.Am2011-3644  0.52
2011 Nath S, Rao S, Tinder TL, Gendler S, Mukherjee P. Abstract 2910: Oncogenic role of MUC1 in context of TGF-β production and signaling Cancer Research. 71: 2910-2910. DOI: 10.1158/1538-7445.Am2011-2910  1
2011 Curry JM, Thompson KJ, Rao S, Ahrens WA, McKillop IH, Sindram D, Iannitti DA, Martinie JB, Mukherjee P. Abstract 2454: Pancreatic cancer stem cells (CSCs) express MUC1 and MUC1-expressing pancreatic cancers encompass higher levels of CSCs Cancer Research. 71: 2454-2454. DOI: 10.1158/1538-7445.Am2011-2454  0.6
2011 Besmer D, Roy LD, Curry J, Tinder T, Manouchehrabadi M, Schettini J, Hwang S, Lee Y, Gendler S, Mukherjee P. Abstract 1070: Pancreatic Ductal Adenocarcinoma (PDA) mice lacking Mucin 1 has a profound defect in tumor growth and metastasis Cancer Research. 71: 1070-1070. DOI: 10.1158/1538-7445.Am2011-1070  0.52
2010 Pinkhasov J, Alvarez ML, Pathangey LB, Tinder TL, Mason HS, Walmsley AM, Gendler SJ, Mukherjee P. Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model. Cancer Immunology, Immunotherapy : Cii. 59: 1801-11. PMID 20824430 DOI: 10.1007/S00262-010-0906-1  0.48
2010 Roy LD, Schettini JL, Gruber HE, Sahraei MM, Mukherjee P. Abstract 4765: Treatment with anti - IL 17 A coupled with COX-2 inhibitor significantly decreases breast cancer associated secondary metastasis in a model of autoimmune arthritis Cancer Research. 70: 4765-4765. DOI: 10.1158/1538-7445.Am10-4765  0.52
2010 Lakshminarayanan V, Bradley JM, Pathangey LB, Mukherjee P, Suman VJ, Madsen CS, Gendler SJ. Abstract 2403: Glycosylated (Tn) and Anchor-Modified MUC1 Peptide Vaccines Induce Effective Anti tumor Immunity and Break Tolerance in MUC1 Transgenic Mice Cancer Research. 70: 2403-2403. DOI: 10.1158/1538-7445.Am10-2403  0.48
2009 Das Roy L, Pathangey LB, Tinder TL, Schettini JL, Gruber HE, Mukherjee P. Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Research : Bcr. 11: R56. PMID 19643025 DOI: 10.1186/Bcr2345  0.48
2009 Poh TW, Bradley JM, Mukherjee P, Gendler SJ. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow. Cancer Research. 69: 3554-62. PMID 19351842 DOI: 10.1158/0008-5472.Can-08-3806  0.48
2009 Mukherjee P, Basu GD, Tinder TL, Subramani DB, Bradley JM, Arefayene M, Skaar T, De Petris G. Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition. Journal of Immunology (Baltimore, Md. : 1950). 182: 216-24. PMID 19109152 DOI: 10.4049/Jimmunol.182.1.216  1
2009 Gendler S, Pathangey L, Lakshminarayanan V, Mukherjee P, Pockaj B, Suman V, Loserth L, Markovic S, Ingle J. Examination of Immune Competence in Breast Cancer Patients at Six Months Post Surgery and Adjuvant Therapy through Assessment of T Cell and Dendritic Cell Functionality. Cancer Research. 69: 4131-4131. DOI: 10.1158/0008-5472.Sabcs-09-4131  0.44
2008 Schettini J, Mukherjee P. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity. Clinical & Developmental Immunology. 2008: 106321. PMID 19190769 DOI: 10.1155/2008/106321  0.44
2008 Tinder TL, Subramani DB, Basu GD, Bradley JM, Schettini J, Million A, Skaar T, Mukherjee P. MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. Journal of Immunology (Baltimore, Md. : 1950). 181: 3116-25. PMID 18713982 DOI: 10.4049/Jimmunol.181.5.3116  1
2008 Roy LD, Pathangey L, Tinder T, Mukherjee P. Breast Cancer Associated Metastasis is Significantly Increased in a Model of Autoimmune Arthritis Nature Precedings. DOI: 10.1038/Npre.2008.2632.1  0.52
2007 Akporiaye ET, Bradley-Dunlop D, Gendler SJ, Mukherjee P, Madsen CS, Hahn T, Besselsen DG, Dial SM, Cui H, Trevor K. Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas. Vaccine. 25: 6965-74. PMID 17707958 DOI: 10.1016/J.Vaccine.2007.06.063  0.48
2007 Mukherjee P, Pathangey LB, Bradley JB, Tinder TL, Basu GD, Akporiaye ET, Gendler SJ. MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model. Vaccine. 25: 1607-18. PMID 17166639 DOI: 10.1016/J.Vaccine.2006.11.007  1
2006 Basu GD, Liang WS, Stephan DA, Wegener LT, Conley CR, Pockaj BA, Mukherjee P. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Research : Bcr. 8: R69. PMID 17156488 DOI: 10.1186/Bcr1626  1
2006 Sevcik MA, Jonas BM, Lindsay TH, Halvorson KG, Ghilardi JR, Kuskowski MA, Mukherjee P, Maggio JE, Mantyh PW. Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer. Gastroenterology. 131: 900-10. PMID 16952558 DOI: 10.1053/J.Gastro.2006.06.021  1
2006 Basu GD, Tinder TL, Bradley JM, Tu T, Hattrup CL, Pockaj BA, Mukherjee P. Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO. Journal of Immunology (Baltimore, Md. : 1950). 177: 2391-402. PMID 16888001 DOI: 10.4049/Jimmunol.177.4.2391  1
2006 Thompson EJ, Shanmugam K, Hattrup CL, Kotlarczyk KL, Gutierrez A, Bradley JM, Mukherjee P, Gendler SJ. Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways. Molecular Cancer Research : McR. 4: 489-97. PMID 16849524 DOI: 10.1158/1541-7786.Mcr-06-0038  0.48
2005 Lindsay TH, Jonas BM, Sevcik MA, Kubota K, Halvorson KG, Ghilardi JR, Kuskowski MA, Stelow EB, Mukherjee P, Gendler SJ, Wong GY, Mantyh PW. Pancreatic cancer pain and its correlation with changes in tumor vasculature, macrophage infiltration, neuronal innervation, body weight and disease progression. Pain. 119: 233-46. PMID 16298491 DOI: 10.1016/J.Pain.2005.10.019  1
2005 Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Breast Cancer Research : Bcr. 7: R422-35. PMID 15987447 DOI: 10.1186/Bcr1019  1
2005 Mukherjee P, Yang SY, Wu B, Song Z, Myers LK, Robbins PD, Wooley PH. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice Annals of the Rheumatic Diseases. 64: 1550-1556. PMID 15860512 DOI: 10.1136/Ard.2004.025619  1
2005 Mukherjee P, Tinder TL, Basu GD, Gendler SJ. MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells Journal of Leukocyte Biology. 77: 90-99. PMID 15513966 DOI: 10.1189/Jlb.0604333  1
2004 Mukherjee P, Tinder TL, Basu GD, Pathangey LB, Chen L, Gendler SJ. Therapeutic efficacy of MUC1-specific cytotoxic T lymphocytes and CD137 co-stimulation in a spontaneous breast cancer model. Breast Disease. 20: 53-63. PMID 15687707 DOI: 10.3233/Bd-2004-20107  0.48
2004 Basu GD, Pathangey LB, Tinder TL, Lagioia M, Gendler SJ, Mukherjee P. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Molecular Cancer Research : McR. 2: 632-42. PMID 15561779  1
2004 Pockaj BA, Basu GD, Pathangey LB, Gray RJ, Hernandez JL, Gendler SJ, Mukherjee P. Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Annals of Surgical Oncology. 11: 328-39. PMID 14993030 DOI: 10.1245/Aso.2004.05.027  1
2003 Mukherjee P, Wu B, Mayton L, Kim SH, Robbins PD, Wooley PH. TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis Annals of the Rheumatic Diseases. 62: 707-714. PMID 12860724 DOI: 10.1136/Ard.62.8.707  1
2003 Chen D, Xia J, Tanaka Y, Chen H, Koido S, Wernet O, Mukherjee P, Gendler SJ, Kufe D, Gong J. Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells. Immunology. 109: 300-7. PMID 12757626 DOI: 10.1046/J.1365-2567.2003.01656.X  0.48
2003 Xia J, Tanaka Y, Koido S, Liu C, Mukherjee P, Gendler SJ, Gong J. Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells. Journal of Immunology (Baltimore, Md. : 1950). 170: 1980-6. PMID 12574367 DOI: 10.4049/Jimmunol.170.4.1980  0.48
2003 Mukherjee P, Madsen CS, Ginardi AR, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ. Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer. Journal of Immunotherapy (Hagerstown, Md. : 1997). 26: 47-62. PMID 12514429 DOI: 10.1097/00002371-200301000-00006  0.48
2002 McConnell EJ, Pathangey LB, Madsen CS, Gendler SJ, Mukherjee P. Dendritic cell-tumor cell fusion and staphylococcal enterotoxin B treatment in a pancreatic tumor model. The Journal of Surgical Research. 107: 196-202. PMID 12429175 DOI: 10.1006/Jsre.2001.6497  0.48
2001 Mukherjee P, Ginardi AR, Madsen CS, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ. MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment. Glycoconjugate Journal. 18: 931-42. PMID 12820727 DOI: 10.1023/A:1022260711583  0.48
2000 Mukherjee P, Ginardi AR, Madsen CS, Sterner CJ, Adriance MC, Tevethia MJ, Gendler SJ. Mice with Spontaneous Pancreatic Cancer Naturally Develop MUC-1-Specific CTLs That Eradicate Tumors When Adoptively Transferred Journal of Immunology. 165: 3451-3460. PMID 10975866 DOI: 10.4049/Jimmunol.165.6.3451  0.48
1999 Kurpad C, Mukherjee P, Wang XUS, Ponnazhagan S, Li L, Yoder MC, Srivastava A. Adeno-associated virus 2-mediated transduction and erythroid lineage- restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells Journal of Hematotherapy and Stem Cell Research. 8: 585-592. PMID 10645765 DOI: 10.1089/152581699319740  1
1998 Ponnazhagan S, Weigel KA, Raikwar SP, Mukherjee P, Yoder MC, Srivastava A. Recombinant human parvovirus B19 vectors: Erythroid cell-specific delivery and expression of transduced genes Journal of Virology. 72: 5224-5230. PMID 9573295 DOI: 10.1128/Jvi.72.6.5224-5230.1998  1
1997 Yoder MC, Hiatt K, Dutt P, Mukherjee P, Bodine DM, Orlic D. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac Immunity. 7: 335-344. PMID 9324354 DOI: 10.1016/S1074-7613(00)80355-6  1
Show low-probability matches.